Virtual Prostate Summit

Online Events

Prostate Cancer Summit

Speakers

Prostate Cancer Summit

  • Andrew J. Armstrong, MD, ScM, FACP

    Andrew J. Armstrong, MD, ScM, FACP

    Andrew J. Armstrong, MD, ScM, FACP

    Associate Professor of Medicine and Surgery

    Andrew J. Armstrong, MD, ScM, FACP, is an associate professor of medicine, surgery, pharmacology and cancer biology at Duke University, and is associate director of the Duke Cancer Institute Genitourinary Clinical Research Program. His work focuses on experimental therapeutics for patients with advanced genitourinary malignancies, with an emphasis on prostate cancer and the investigation of biomarkers of response and benefit. Dr Armstrong has developed numerous experimental agents in prostate and renal cell cancer, and is involved in the leadership of multiple ongoing phase 1-4 treatment and biomarker trials in men with advanced prostate cancer. He co-chaired the Prostate Cancer Working Group 3 and is a leading member of the NCCN Prostate Cancer panel.
  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Director of Genitourinary Medical Oncology

    Daniel J. George, MD, is professor of medicine and surgery, Divisions of Medical Oncology and Urology, Duke University School of Medicine, and has appointments in the Duke Clinical Research Institute and Duke Cancer Institute, where he is the director of Genitourinary (GU) Oncology. His areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. Dr George is principal investigator of the Duke site for the Department of Defense (DOD) Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. He is the PI of the MaRCC registry in advanced renal cell carcinoma and co-PI of the PCF 5000, an international, multi-sponsor supported registry in advanced prostate cancer.

All Speakers

  • Andrew J. Armstrong, MD, ScM, FACP

    Andrew J. Armstrong, MD, ScM, FACP

    Andrew J. Armstrong, MD, ScM, FACP

    Associate Professor of Medicine and Surgery

    Andrew J. Armstrong, MD, ScM, FACP, is an associate professor of medicine, surgery, pharmacology and cancer biology at Duke University, and is associate director of the Duke Cancer Institute Genitourinary Clinical Research Program. His work focuses on experimental therapeutics for patients with advanced genitourinary malignancies, with an emphasis on prostate cancer and the investigation of biomarkers of response and benefit. Dr Armstrong has developed numerous experimental agents in prostate and renal cell cancer, and is involved in the leadership of multiple ongoing phase 1-4 treatment and biomarker trials in men with advanced prostate cancer. He co-chaired the Prostate Cancer Working Group 3 and is a leading member of the NCCN Prostate Cancer panel.
  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Director of Genitourinary Medical Oncology

    Daniel J. George, MD, is professor of medicine and surgery, Divisions of Medical Oncology and Urology, Duke University School of Medicine, and has appointments in the Duke Clinical Research Institute and Duke Cancer Institute, where he is the director of Genitourinary (GU) Oncology. His areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. Dr George is principal investigator of the Duke site for the Department of Defense (DOD) Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. He is the PI of the MaRCC registry in advanced renal cell carcinoma and co-PI of the PCF 5000, an international, multi-sponsor supported registry in advanced prostate cancer.

Partners

Academic

Associations

Publishers